Adverum Clinical Site 219 — Winston-Salem, North Carolina

Adverum Clinical Site 219 is a clinical research site located in Winston-Salem, North Carolina, United States 27103.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Adverum Clinical Site 219 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Sponsors: Adverum Biotechnologies, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Winston-Salem

Browse all research sites in North Carolina · View every site in Winston-Salem

• Wake Forest University Heath Sciences
• Atrium Health Wake Forest University Health Sciences
• Wake Forest University, Baptist Medicial Center
• Wake Forest University Baptist Medical Center OutpatientCmprehensivCancerCtr
• Atrial Health Brenner Children's Hospital( Wake Forest)
• Wake Forest Baptist Hospital - Plastic and Reconstructive Surgery
• Wake Forest University Clinical Research Unit
• Wake Forest Baptist University Medical Center
• Wake Forest University/Atrium Health's Carolinas Medical Center
• Comprehensive Cancer Center at Wake Forest University
• Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center
• Wake Forest University School of Medicine_Atrium Health Wake Forest Baptist

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adverum Clinical Site 219?

Adverum Clinical Site 219 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adverum Clinical Site 219 conducted?

Adverum Clinical Site 219 has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Is Adverum Clinical Site 219 accredited by Crixeo Clinical Trials?

Adverum Clinical Site 219 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adverum Clinical Site 219?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.